Ubs Group Ag Deciphera Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$13.58 - $17.36 $544,761 - $696,396
40,115 Added 31.76%
166,438 $2.62 Million
Q4 2023

Feb 09, 2024
BUY
$10.11 - $16.54 $688,127 - $1.13 Million
68,064 Added 116.83%
126,323 $2.04 Million
Q3 2023

Nov 09, 2023
SELL
$12.46 - $15.48 $387,917 - $481,938
-31,133 Reduced 34.83%
58,259 $741,000
Q2 2023

Aug 11, 2023
SELL
$13.28 - $15.96 $79,733 - $95,823
-6,004 Reduced 6.29%
89,392 $1.26 Million
Q1 2023

May 12, 2023
SELL
$14.26 - $22.1 $1.05 Million - $1.63 Million
-73,944 Reduced 43.67%
95,396 $1.47 Million
Q4 2022

Feb 08, 2023
BUY
$14.85 - $19.04 $1.91 Million - $2.44 Million
128,397 Added 313.6%
169,340 $2.78 Million
Q3 2022

Nov 10, 2022
SELL
$12.38 - $20.23 $775,124 - $1.27 Million
-62,611 Reduced 60.46%
40,943 $758,000
Q2 2022

Aug 10, 2022
SELL
$9.11 - $13.98 $2.81 Million - $4.31 Million
-308,424 Reduced 74.86%
103,554 $1.36 Million
Q1 2022

May 16, 2022
SELL
$6.87 - $11.11 $236,334 - $382,195
-34,401 Reduced 7.71%
411,978 $3.82 Million
Q4 2021

Feb 14, 2022
BUY
$7.7 - $37.13 $3.2 Million - $15.4 Million
415,783 Added 1358.95%
446,379 $4.36 Million
Q3 2021

Nov 15, 2021
BUY
$26.46 - $37.15 $539,810 - $757,897
20,401 Added 200.11%
30,596 $1.04 Million
Q2 2021

Aug 13, 2021
SELL
$32.73 - $47.95 $1.01 Million - $1.48 Million
-30,866 Reduced 75.17%
10,195 $373,000
Q1 2021

May 12, 2021
BUY
$40.39 - $56.73 $777,669 - $1.09 Million
19,254 Added 88.29%
41,061 $1.84 Million
Q4 2020

Feb 11, 2021
BUY
$51.77 - $66.18 $120,261 - $153,736
2,323 Added 11.92%
21,807 $1.25 Million
Q3 2020

Nov 12, 2020
BUY
$43.8 - $58.16 $226,533 - $300,803
5,172 Added 36.14%
19,484 $1 Million
Q2 2020

Jul 31, 2020
BUY
$37.05 - $65.03 $421,147 - $739,196
11,367 Added 385.98%
14,312 $855,000
Q1 2020

May 01, 2020
SELL
$33.63 - $69.4 $239,075 - $493,364
-7,109 Reduced 70.71%
2,945 $121,000
Q4 2019

Feb 14, 2020
SELL
$31.7 - $69.93 $1.49 Million - $3.28 Million
-46,875 Reduced 82.34%
10,054 $625,000
Q3 2019

Nov 14, 2019
BUY
$19.95 - $38.85 $921,131 - $1.79 Million
46,172 Added 429.23%
56,929 $1.93 Million
Q2 2019

Aug 14, 2019
BUY
$21.05 - $26.21 $61,613 - $76,716
2,927 Added 37.38%
10,757 $243,000
Q1 2019

May 14, 2019
SELL
$20.65 - $29.55 $852,287 - $1.22 Million
-41,273 Reduced 84.05%
7,830 $182,000
Q4 2018

Feb 14, 2019
BUY
$19.08 - $36.14 $837,459 - $1.59 Million
43,892 Added 842.3%
49,103 $1.03 Million
Q3 2018

Nov 14, 2018
SELL
$33.57 - $42.1 $37,866 - $47,488
-1,128 Reduced 17.79%
5,211 $202,000
Q2 2018

Aug 14, 2018
BUY
$20.06 - $44.95 $33,279 - $74,572
1,659 Added 35.45%
6,339 $250,000
Q1 2018

May 15, 2018
BUY
$20.04 - $29.71 $5,470 - $8,110
273 Added 6.19%
4,680 $94,000
Q4 2017

Feb 14, 2018
BUY
$16.54 - $24.2 $72,891 - $106,649
4,407
4,407 $100,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email